Cascade Medical had a U.S. distribution relationship with MTF prior to this sale. The company’s Cascade System will now be distributed by ConMed Linvatec. The system is cleared by the FDA and designed for use in the preparation of autologous PRP from a sample of the patient’s blood. The PRP can also be mixed with autograft and allograft bone before applying it to a surgical site.
The proprietary aspect of the technology is its ability to produce liquid, gel and membrane formats for PRP.
Related Articles on Orthopedic Devices:
Wright Medical Group Launches Foot and Ankle Systems
Synthes Takes on 3 Former Sales Reps, Stryker in Loyalties Case
Symmetry Medical Completes Acquisition of Surgical Implants Company
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.